Recruiting Long COVID Studies in Aurora
RECOVER-SLEEP: Platform Protocol
The platform protocol is designed to be flexible so that it is suitable for a range of study settings and intervention types. Therefore, the platform protocol provides a general protocol structure tha...
NE3107 in Adults With Neurological Symptoms of Long COVID
Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in ...
About Long COVID Clinical Trials in Aurora
Long COVID (post-acute sequelae of SARS-CoV-2) refers to symptoms persisting weeks to months after the initial COVID-19 infection. Symptoms can include fatigue, brain fog, breathlessness, and joint pain. Research is actively investigating causes and treatments for this complex condition.
There are currently 2 long covid clinical trials recruiting participants in Aurora, COLORADO. These studies are seeking a combined 1,282 participants. Research is being sponsored by Duke University, BioVie Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Long COVID Clinical Trials in Aurora — FAQ
Are there long covid clinical trials in Aurora?
Yes, there are 2 long covid clinical trials currently recruiting in Aurora, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Aurora?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.
Are clinical trials in Aurora free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.
What long covid treatments are being tested?
The 2 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for long covid.
Data updated March 2, 2026 from ClinicalTrials.gov